Becker, Pamela S <br/><br/>
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.  [electronic resource] 

 -  British journal of haematology  Oct 2011 
 - 182-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2011.08831.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Cytarabine--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Infections--etiology<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Proportional Hazards Models<br/>Recurrence<br/>Remission Induction<br/>Risk<br/>Salvage Therapy<br/>Young Adult